PSORIASIS is a chronic inflammatory skin disease influenced by both genetic and environmental factors, affecting ...

While pharmacologic therapies remain central to managing PsO and PsA, non-pharmacologic interventions also play a crucial ...

Mar. 3, 2025 — Psoriasis is one of the most common chronic inflammatory skin diseases, affecting around 250,000 people in Austria. While previous treatment approaches have mainly focused on ...

Casey Gallagher, MD, a board-certified dermatologist and clinical professor, discusses how patients manage psoriasis and some exciting treatments on the horizon.

After finding and optimising two sequences of three amino acids that showed biological activity comparable to the full-length ...

Sun Pharma announced its partnership with music icon and ILUMYA® (tildrakizumab-asmn) patient, Art Garfunkel, as he shares ...

University of Birmingham The study is part of a wider research programme on PEPITEM and its potential use in therapies for ...

Treatments for COPD, psoriasis, and neuroendocrine tumors, as well as a next-generation COVID-19 vaccine are under review.